The U.S. House passed a bill on a bipartisan 232-193 vote that would limit the price of insulin for Americans with health insurance. Democratic Senators Warnock of Georgia and Patty Murray of Washington state held a round table virtually consisting of residents from both states to push for capping the cost of insulin at $35. Both parties argued that insulin is a life-saving drug, and there should be no reason for the cost of this medicine to rise the way it is. The senators were joined by citizens who have experienced diabetes firsthand.
Initially, this provision was incorporated in the President’s “Build Back Better” social spending and climate package sent to Congress that was delayed in Senate. Having insulin rationed because it’s too expensive poses a direct threat to people’s health. That’s why there is an effort to cap insulin costs.
The Kaiser Family Foundation (KFF) is a nonprofit organization that focuses on national health issues. The organization conducted research and found that Medicare spending on insulin increased 840%, from $1.4 billion to $13.3 billion. Kevin Wren, a Type I diabetes patient from Washington state, announced that the cost of his insulin was sometimes more than his rent. This bill will lower costs for nearly 40 million Americans and save lives.
A press conference was held by Craig and Democratic Reps. Lucy McBath of Georgia and Dan Kildee of Michigan, and Majority Whip Jim Clyburn of South Carolina, to advocate for the measure passed by the House, the “Affordable Insulin Act.” This bill would ensure that no patient will pay more than $35 for a 30-day supply of insulin. A total of 12 Republicans voted with the Democrats for the bill.
Members who attended this conference hope that Congress will send the legislation to President Joe Biden for his signature. His signature will lower drug costs for millions of American families. One in four Americans who need insulin has stated they needed to cut back or have skipped doses because the price is too high.
GMS Helps You Live A Healthier Lifestyle
When partnering with GMS, you can utilize our buying power through economies of scale to access more affordable and comprehensive healthcare options. GMS’ savings, on average, are 23% lower for employee premiums and 34% lower for family premiums. We recently launched our diabetic management program with One Drop, which helps employers and their employees transform their health, change lives, and create new opportunities. Learn more about how GMS can provide you with the resources to save you and your employees time and money.